Neurocrine Biosciences NBIX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $668.6M+119% | $478.6M+40.2% | $428M+10.9% | $348.3M+2.7% | $305.8M-17.3% | ||
| $26.6M+7.3% | $26M+10.6% | $25.8M+16.2% | $24.7M+16.5% | $24.8M+30.5% | ||
| $222.3M+9.1% | $217.9M+11.5% | $225.7M+35.0% | $213.5M+23.1% | $203.8M+2.5% | ||
| $863.7M+63.0% | $782.7M+31.5% | $636.8M+33.7% | $567.3M+7.0% | $529.9M-17.9% | ||
| $34.8M-7.7% | $36.4M-4.7% | $43.7M+20.4% | $38.6M+7.8% | $37.7M+21.6% | ||
| -$784.8M— | -$264.4M— | -$279.8M— | —— | —— | ||
| —— | —— | —— | $467.7M— | $450M— | ||
| —— | —— | —— | -$411.2M-143% | -$700.9M-652% | ||
| $72.4M+136% | $480M+2,752% | -$8.9M-116% | $124.3M+706% | -$202.2M— | ||
| $831.3M+68.9% | $748.7M+34.4% | $593.1M+34.8% | $528.7M+6.9% | $492.2M-19.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Neurocrine Biosciences generate?
- Neurocrine Biosciences (NBIX) generated $863.7M in operating cash flow over the trailing twelve months.
- What is Neurocrine Biosciences's free cash flow?
- After $34.8M of capital expenditures, Neurocrine Biosciences's free cash flow was $831.3M over the trailing twelve months, up 68.9% year over year.
- Where does Neurocrine Biosciences's cash flow data come from?
- Every line is extracted from Neurocrine Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
